• Home
  • Research areas
    • ADME-Tox
    • Biomarkers
    • Cell Biology and Signalling
    • Cell Sourcing – Cell Culture Technologies
    • Drug Discovery
    • Gene Expression – Molecular Biology
    • Stem Cells
    • Supplying Discovery Tools
  • Contact us
  • Meet the authors
  • Facebook
  • Google+
  • LinkedIn
  • Twitter
  • YouTube
Home
Research areas
    ADME-Tox
    Biomarkers
    Cell Biology and Signalling
    Cell Sourcing - Cell Culture Technologies
    Drug Discovery
    Gene Expression - Molecular Biology
    Stem Cells
    Supplying Discovery Tools
Contact us
Meet the authors
tebu-bio's blog - Acting and reacting in life sciences and biotechnologies
  • Home
  • Research areas
    • ADME-Tox
    • Biomarkers
    • Cell Biology and Signalling
    • Cell Sourcing – Cell Culture Technologies
    • Drug Discovery
    • Gene Expression – Molecular Biology
    • Stem Cells
    • Supplying Discovery Tools
  • Contact us
  • Meet the authors
Drug Discovery

Screen for inhibitors of PD-1 signalling with a complete cellular assay system

28/10/2016 by Ali El Baya, PhD No Comments
T cell - Cancer cell CAR-T Cells, Cancer Immuno-therapy, Immune-checkpoints

Immunotherapy represents a field in Drug Discovery which is quickly developing and leading to significant progress in treatments of a number of diseases, especially cancer. The approach is based on inducing, enhancing, or surpressing an immune response. Therapeutic manipulation of immunopathways has led to promising clinical results . The first therapeutic antibodies directed against the checkpoint receptor PD-1 have been already brought to the market (Nivolumab, Pembrolizumab) by Bristol Myers Squibb and Merck/MSD respectively, and approved for the treatment of diverse cancer types.

Today, I would like to review tools to build up a comprehensive assay set up for  cell based inhibitor screening on PD-1 / PD-L1/PD-L2 binding.

Continue reading
Drug Discovery

Cancer Immunotherapy: Generate your PD-L1 target cell line

06/04/2016 by Ali El Baya, PhD No Comments
T cell - Cancer cell CAR-T Cells, Cancer Immuno-therapy, Immune-checkpoints
T cell - APC effects

Fig 1: Immuno checkpoint proteins on T cell interact with ligands on APCs or cancer cells

In a recent post,  I invited you to discover a cell line provided by BPS Bioscience over-expressing the checkpoint receptor PD-1. They have now just released a new kit which allows to generate a PD-L1 and TCR activator over-expressing target cell line.

Continue reading
Drug Discovery

How to screen for inhibitors of PD-1 signalling in a cellular assay

09/02/2016 by Ali El Baya, PhD No Comments
T cell - Cancer cell CAR-T Cells, Cancer Immuno-therapy, Immune-checkpoints
PD1 - PD-L1 - PD-L2

Fig 1: Immuno checkpoint proteins on T cell interact with ligands on APCs or cancer cells

The treatment of diseases by inducing, enhancing, or surpressing an immune response is referred to as Immunotherapy. Therapeutic manipulation of immunopathways has led to promising clinical results for the treatment of a number of diseases. The first therapeutic antibodies directed against the checkpoint receptor PD-1 have been already brought to the market (Nivolumab, Pembrolizumab) by Bristol Myers Squibb and Merck/MSD respectively, and approved for the treatment of diverse cancer types.

Today, I would like to review a versatile tool to conduct cell based inhibitor screenings on PD-1 / PD-L1/PD-L2 binding.

Continue reading
Drug Discovery

9 pathway-specific screening assays in Immunotherapy

02/07/2015 by Ali El Baya, PhD No Comments
The immune system is a system of cells and organs whose function is to defend an organism from foreign pathogens. With the ability to mount a response against virtually any foreign material and return to a quiescent state following neutralization of the threat, this fascinating organ system displays remarkable specificity and plasticity. To achieve this, there is a multifaceted balancing act between the many activators and suppressors which maintains homeostasis of the body’s perhaps most complex organ system.
Continue reading
tebu-bio

LAB SERVICES OUTSOURCING

• Protein production

• Plasmid Preps

• 3D Cell Culture
LEARN MORE

Most popular posts

  • HeLa cells: Origin of this important cell line in life science research
  • From RUO to IVD - the acronym guide to reagents' intended use
  • Differentiate between Apoptosis, Necroptosis, Autophagy & Ferroptosis
  • How to choose the perfect buffer to get a pure, stabilised, functional protein
  • Differentiate between K48- and K63-specific Ubiquitination
My Tweets

Top contributors

Dimitri Szymczak, PhD
Dimitri Szymczak, PhD
  • Get closer to the real Host Cell Protein (HCP) quantity
  • How to obtain reliable DNA and RNA quantitation
Frédéric Samazan
Frédéric Samazan
  • Lympholyte®: The ideal tool for simple and viable lymphocytes isolation
  • CAR T-Cell therapy: new hope for Immunotherapy and Cancer treatment
Isabelle Nobiron
Isabelle Nobiron
  • Proteomics Biostats: get the most out of your array data
  • Hepatic Hyaluronan Content increased by Alcohol Consumption in Patients with Liver Steatosis
Isabelle Topin, PhD
Isabelle Topin, PhD
  • Monoclonal antibodies – all you need to know about antibody generation
  • Tips and Tricks: how to increase unstable protein expression in E. Coli
Philippe Fixe, PhD
Philippe Fixe, PhD
  • 10 Human Immune Checkpoint biomarkers quantified simultaneously
  • 3D cell culture: discover the new VitroGel™ 3D Hydrogel system

Copyright © 2018 - tebu-bio - visit our main website at tebu-bio.com